Thromboelastometry in the perioperative setting

Netherlands Journal of Critical Care

Volumn 14, Issue 1, 2010, Pages 23-31

  Schochl H ^a,b   Solomon, C ^c   Voelckel, W ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUVA Trauma Hospital   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood management; Coagulation monitoring; Haemorrhage; POC; Thrombelastography; Thromboelastometry

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; HEMOSTATIC AGENT; HEPARIN; HEPARINOID; PROCOAGULANT;

ALGORITHM; BLEEDING; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; COST; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HEART SURGERY; HELLP SYNDROME; HUMAN; INJURY; INJURY SCALE; LABORATORY PERSONNEL; LIVER SURGERY; LIVER TRANSPLANTATION; MEDICAL AUDIT; MONITORING; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PREDICTION; PREECLAMPSIA; PROTHROMBIN TIME; QUALITY CONTROL; RELIABILITY; REOPERATION; REVIEW; SURGICAL TECHNIQUE; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY;

EID: 77649210257     PISSN: 15693511     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Geeraedts LM, Demiral H, Schaap NP, et al. 'Blind' transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007;73:382-388
2. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost. 2005;3:2607-2611.
3. Dzik WH Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004:3:324-330
4. Luddington RJ, Thromboelastography/thromboelastometry. Clin Lab Haem 2005;27:81-90
5. Hoffman M, Monroe D. A cell based model of hemostasis. Thromb Haemost 2001;85:958-965
6. Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005;89:123-127
7. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009;108:751-758
8. Dempfle CE, Borggrefe M. Point of care coagulation tests in critically ill patients. Semin Thromb Hemost. 2008;34:445-50.
9. Wilson RF, Dulchavsky SA, Soullier G, et al.: Problems with 20 or more blood transfusions in 24 hours. Am Surg; 1987;53:410-7
10. Plotkin AJ, Wade CE, Jenkins DH, Smith KA, Noe JC, Park MS, Perkins JG, Holcomb JB. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma. 2006;64(2 Suppl):S64-68
11. Hartert H: Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948;26:577-583
12. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anest Analg 2008;106:1366-1375
13. Lang T, Bauters A, Braun SL et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis. 2005;16:301-10
14. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193
15. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007; 3:680-685
16. Spahn DR, Cerny V, Coats TJ, et al. Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;11:R17
17. Kheirabadi BS, Crissey JM, Deguzman R, Holcomb JB. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma. 2007;62:1352-1259
18. Martini WZ, Cortez DS, Dubick MA, Park MS, Hocomb JB. Thromb-elastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008;65:535-543
19. Kashuk JL, Moore EE. Thrombelastography: goal directed therapy of postinjury coagulopathy. Am J Trauma. In press
20. Schöchl H: Coagulation management in major trauma. Hämostasiologie 2006;26S21-S29
21. Teusinger OM, Spahn D, Hofer DR, Ganter T. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anasthesiol 2009;22:305-312
22. Kaufman CR, Dwyer KN, Cruz JD, Dols SJ, Trask AL: Usefulness of thromboelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716-20
23. Schöchl H , Frietsche T, Pavelka M, Jambor C. Hyperfibrinolysis following major trauma: differential diagnosis of lysis patterns and prognostic value of thromboelastometry. J Trauma 2009;67:125-131
24. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5:289-95.
25. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma related massive bleeding. Curr Opin Anasthesiol 2009;22:267-274
26. Schöchl H, Solomon C, Jambor C, Hofer G, Scharbert G, Voelckel W, Kozek-Langenecker S. Goal directed coagulation management of major trauma patients with fibrinogen and prothrombin complex concentrates - Experience of a single, level-one trauma centre. Submitted for publication
27. Görlinger K., Jambor C: Coagulation management during liver transplantation. Hämostaseologie 2006;26: S64-S75
28. Steib A, Gengenwin N, Freys G, Boudjema K, Levy S, Otteni JC. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 1994;73:645-648
29. Kettner S., Gonano C., Seebach F., Sitzwohl C., Acimovix S., Stark J., Schellongowski A., Baicher A., Felfernig M., Zimpfer M. Endogenous herapin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998;86:691-695
30. Sankey EA, CrowJ, Mallett SV. Pulmonary platelet aggregates:possible cause of sudden preoperative death in adults undergoning liver transplantation. J Clin Pathol 1993;46:222-227
31. Kang Y. Thromboelastography in liver transplantation. Semin Thromb Hemost 1995;21 (Suppl 4): 34-44
32. Kang YG, Marin DJ, Marquez J, Lewis JH, Bon tempo FA, Schaw BW, Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1885;64:888-896
33. Schmann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003;97:21-28
34. Praparella D, Brister S, Buchanan M. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Medicine 2004;30:1873-1881
35. Gelb AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW, Cloutier M, Verrier E, Mangano DT: Changes in blood coagulation during and following cardiopulmonary bypass. Am J Clin Pathol 1996;106:87-99
36. Spiess B, Truman K, McCarthy R. Thrombelastography as an indicator of post cardiopulmonary bypass coagulopathy. J Clin Monit 1987;3:25-30
37. Martin P, Horkay F, Rajah SM, Walker DR. Monitoring of coagulation status using thrombelastography during paediatric open heart surgery. Int J Clin Monitoring Comp 1991;8:183-187
38. Craig J, Aguiar-Ibanez R, Bhattacharya S, Downie S, Duff S, Kohli H, Nimmo A, True man P, Wilson S, Yunni Y. The clinical and cost effectiveness of thromboelastography/thromboelastometry. Health Tech Ass 2008;11:1-70
39. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: A Pilot Study. Heart Lung Circ. 2008, doi:10.106/j.hlc.1008.08. 016
40. Spiess BD, Gillies BSA, Chandler W, Verrier E: Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995;9:168-73
41. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 1999;88:312-9
42. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinise-modified thrombelastography during cardiopulmonary bypass. Br J Anaest 2001;86:575-578
43. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006;16:31-9
44. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Plichlmaier A. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thoracic Cardiovas Surg 2009;102:785-792
45. Lang T, von Depka M: Possibilities and limitations of thrombelastometry/graphy. Hämostasiologie 2006;26:S21-S29
46. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100:792-797.
47. Spiel AO, Mayr FB, Firbas C. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost. 2006;4:411-416
48. Sharma SK, Phillip J, Whitten CW, Padakandla WB, Landers DF: Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999;90:385-90
49. Huissoud C; Carrabin N; Audibert F; Levrat A; Massignon D; Berland M; Rudigoz RC. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009;116:1097-102
50. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-273.
51. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R. A practical concept for preoperative identification of patients with impaired primary haemostasis. Cli Appl Thrombosis/Haemostasis 2004; 10:195-204
52. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008 Jul;34(1):73-92
53. Haas T, Fries D, Velik-Salchner C, et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008;106:725-731
54. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth. 2009 Jun;102(6):785-92.
55. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost. 2009 May;7(5):795-802.
56. Korte WC, Szadkowski C, Gähler A, Gabi K, Kownacki E, Eder M, Degiacomi P, Zoller N, Devay J, Lange J, Schnider T. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology. 2009 Feb;110(2):239-45.Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008 Jul;34(1):73-92
57. Samama CM, Ozier Y. Near patient testing of haemostasis in the operating theatre: an approach to appropriate use of blood in surgery. Vox Sanguinis 2003;84:251-255
58. Calatzis AN, Fritzsche P, Calatzis AL, Kling M, Hipp R, Stemberger A. A comparison of the technical principle of the roTEG coagulation analyser and conventional thrombelastographic systems. Ann Hematol 1996;72(S1):87
59. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprinia JA: Comparison of thromboelastography with common coagulation tests. Thromb Haemostas 1981;46:752-6
60. Lang T, Ramschak H, Lakner M, Toller W, Gütl M, Mahla E, März W, Halwachs- Baumann, G. Evaluation the FIBTEG-S reagent on the ROTEG® . Haemostaseologie 2004;24(S):A83
61. Fenyvesi T, Lakner M, Träger I, Giese C, Harenberg J. Effect of direct thrombin inhibitors, unfractionated heparin, low molecular weight heparins dalteparin and enoxaparin and of the haparinoid danaparoid on the rotation thromboelastometry method (ROTEM® ). Haemostaseologie 2005;25(S):P138
62. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004;2(1):102-110
63. Schroeder V, Chatterjee T, Kohler HP. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 2001;104:467-474
64. Kaur J, Jones N, Mallet S. Thrmbelastography PlateletMapping is a useful preoperative tool in surgical patients taking antiplatelet medication. Br J Anaesth 2009; 103: 304
65. Schobersberger W, Fries D, Mittermayr M, Innerhofer P, Sumann M, Schobersberger B, Klingler A, Stollnberger V, Fischbach U, Gunga HC. Changes of biochemical markers and functional tests for clot formation during long-haul flights. Thromb Res 2003;103:19-24
66. Franz RC. ROTEM analysis: a significant advance in the field of rotational thrombelastography. SAJS 2009;47(1):2-6
67. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg. 2007;31:1052-1057